Article
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.
Nature communications - 21 Sept 2021
Meyer Bjoern, Chiaravalli Jeanne, Gellenoncourt Stacy, Brownridge Philip, Bryne Dominic P, Daly Leonard A, Grauslys Arturas, Walter Marius, Agou Fabrice, Chakrabarti Lisa A, Craik Charles S, Eyers Claire E, Eyers Patrick A, Gambin Yann, Jones Andrew R, Sierecki Emma, Verdin Eric, Vignuzzi Marco, Emmott Edward
Abstract excerpt
SARS-CoV-2 is the causative agent behind the COVID-19 pandemic, responsible for over 170 million infections, and over 3.7 million deaths worldwide. Efforts to test, treat and vaccinate against this pathogen all benefit from an improved understanding of the basic biology of SARS-CoV-2. Both viral and cellular proteases play a crucial role in SARS-CoV-2 replication. Here, we study proteolytic cleavage of viral and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
